SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:1999 4915 "

Sökning: L773:1999 4915

  • Resultat 1-10 av 194
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Abdurakhmanov, Eldar, 1977-, et al. (författare)
  • Biophysical Mode-of-Action and Selectivity Analysis of Allosteric Inhibitors of Hepatitis C Virus (HCV) Polymerase
  • 2017
  • Ingår i: Viruses. - : MDPI AG. - 1999-4915. ; 9:6
  • Tidskriftsartikel (refereegranskat)abstract
    • Allosteric inhibitors of hepatitis C virus (HCV) non-structural protein 5B (NS5B) polymerase are effective for treatment of genotype 1, although their mode of action and potential to inhibit other isolates and genotypes are not well established. We have used biophysical techniques and a novel biosensor-based real-time polymerase assay to investigate the mode-of-action and selectivity of four inhibitors against enzyme from genotypes 1b (BK and Con1) and 3a. Two thumb inhibitors (lomibuvir and filibuvir) interacted with all three NS5B variants, although the affinities for the 3a enzyme were low. Of the two tested palm inhibitors (dasabuvir and nesbuvir), only dasabuvir interacted with the 1b variant, and nesbuvir interacted with NS5B 3a. Lomibuvir, filibuvir and dasabuvir stabilized the structure of the two 1b variants, but not the 3a enzyme. The thumb compounds interfered with the interaction between the enzyme and RNA and blocked the transition from initiation to elongation. The two allosteric inhibitor types have different inhibition mechanisms. Sequence and structure analysis revealed differences in the binding sites for 1b and 3a variants, explaining the poor effect against genotype 3a NS5B. The indirect mode-of-action needs to be considered when designing allosteric compounds. The current approach provides an efficient strategy for identifying and optimizing allosteric inhibitors targeting HCV genotype 3a.
  •  
2.
  • Amer, Fatma, et al. (författare)
  • Temporal Dynamics of Influenza A(H5N1) Subtype before and after the Emergence of H5N8
  • 2021
  • Ingår i: Viruses. - : MDPI. - 1999-4915. ; 13:8
  • Tidskriftsartikel (refereegranskat)abstract
    • Highly pathogenic avian influenza (HPAI) viruses continue to circulate worldwide, causing numerous outbreaks among bird species and severe public health concerns. H5N1 and H5N8 are the two most fundamental HPAI subtypes detected in birds in the last two decades. The two viruses may compete with each other while sharing the same host population and, thus, suppress the spread of one of the viruses. In this study, we performed a statistical analysis to investigate the temporal correlation of the HPAI H5N1 and HPAI H5N8 subtypes using globally reported data in 2015-2020. This was joined with an in-depth analysis using data generated via our national surveillance program in Egypt. A total of 6412 outbreaks were reported worldwide during this period, with 39% (2529) as H5N1 and 61% (3883) as H5N8. In Egypt, 65% of positive cases were found in backyards, while only 12% were found in farms and 23% in live bird markets. Overall, our findings depict a trade-off between the number of positive H5N1 and H5N8 samples around early 2017, which is suggestive of the potential replacement between the two subtypes. Further research is still required to elucidate the underpinning mechanisms of this competitive dynamic. This, in turn, will implicate the design of effective strategies for disease control.
  •  
3.
  • Andersen, Petter I., et al. (författare)
  • Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine
  • 2019
  • Ingår i: Viruses. - : MDPI. - 1999-4915. ; 11:10
  • Tidskriftsartikel (refereegranskat)abstract
    • Viruses are the major causes of acute and chronic infectious diseases in the world. According to the World Health Organization, there is an urgent need for better control of viral diseases. Repurposing existing antiviral agents from one viral disease to another could play a pivotal role in this process. Here, we identified novel activities of obatoclax and emetine against herpes simplex virus type 2 (HSV-2), echovirus 1 (EV1), human metapneumovirus (HMPV) and Rift Valley fever virus (RVFV) in cell cultures. Moreover, we demonstrated novel activities of emetine against influenza A virus (FLUAV), niclosamide against HSV-2, brequinar against human immunodeficiency virus 1 (HIV-1), and homoharringtonine against EV1. Our findings may expand the spectrum of indications of these safe-in-man agents and reinforce the arsenal of available antiviral therapeutics pending the results of further in vitro and in vivo tests.
  •  
4.
  • Aralaguppe, SG, et al. (författare)
  • MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors
  • 2019
  • Ingår i: Viruses. - : MDPI AG. - 1999-4915. ; 11:9
  • Tidskriftsartikel (refereegranskat)abstract
    • The detection of drug resistance mutations (DRMs) in minor viral populations is of potential clinical importance. However, sophisticated computational infrastructure and competence for analysis of high-throughput sequencing (HTS) data lack at most diagnostic laboratories. Thus, we have proposed a new pipeline, MiDRMpol, to quantify DRM from the HIV-1 pol region. The gag-vpu region of 87 plasma samples from HIV-infected individuals from three cohorts was amplified and sequenced by Illumina HiSeq2500. The sequence reads were adapter-trimmed, followed by analysis using in-house scripts. Samples from Swedish and Ethiopian cohorts were also sequenced by Sanger sequencing. The pipeline was validated against the online tool PASeq (Polymorphism Analysis by Sequencing). Based on an error rate of <1%, a value of >1% was set as reliable to consider a minor variant. Both pipelines detected the mutations in the dominant viral populations, while discrepancies were observed in minor viral populations. In five HIV-1 subtype C samples, minor mutations were detected at the <5% level by MiDRMpol but not by PASeq. MiDRMpol is a computationally as well as labor efficient bioinformatics pipeline for the detection of DRM from HTS data. It identifies minor viral populations (<20%) of DRMs. Our method can be incorporated into large-scale surveillance of HIV-1 DRM.
  •  
5.
  • Arnberg, Niklas, 1987-, et al. (författare)
  • Special issue "adenovirus pathogenesis"
  • 2021
  • Ingår i: Viruses. - : MDPI. - 1999-4915. ; 13:6
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • Adenovirus is a common cause of disease in humans and in animals [...]
  •  
6.
  • Arsın, Hasan, et al. (författare)
  • Exploring Codon Adjustment Strategies towards Escherichia coli-Based Production of Viral Proteins Encoded by HTH1, a Novel Prophage of the Marine Bacterium Hypnocyclicus thermotrophus
  • 2021
  • Ingår i: Viruses. - : MDPI AG. - 1999-4915. ; 13:7
  • Tidskriftsartikel (refereegranskat)abstract
    • Marine viral sequence space is immense and presents a promising resource for the discovery of new enzymes interesting for research and biotechnology. However, bottlenecks in the functional annotation of viral genes and soluble heterologous production of proteins hinder access to downstream characterization, subsequently impeding the discovery process. While commonly utilized for the heterologous expression of prokaryotic genes, codon adjustment approaches have not been fully explored for viral genes. Herein, the sequence-based identification of a putative prophage is reported from within the genome of Hypnocyclicus thermotrophus, a Gram-negative, moderately thermophilic bacterium isolated from the Seven Sisters hydrothermal vent field. A prophage-associated gene cluster, consisting of 46 protein coding genes, was identified and given the proposed name Hypnocyclicus thermotrophus phage H1 (HTH1). HTH1 was taxonomically assigned to the viral family Siphoviridae, by lowest common ancestor analysis of its genome and phylogeny analyses based on proteins predicted as holin and DNA polymerase. The gene neighbourhood around the HTH1 lytic cassette was found most similar to viruses infecting Gram-positive bacteria. In the HTH1 lytic cassette, an N-acetylmuramoyl-L-alanine amidase (Amidase_2) with a peptidoglycan binding motif (LysM) was identified. A total of nine genes coding for enzymes putatively related to lysis, nucleic acid modification and of unknown function were subjected to heterologous expression in Escherichia coli. Codon optimization and codon harmonization approaches were applied in parallel to compare their effects on produced proteins. Comparison of protein yields and thermostability demonstrated that codon optimization yielded higher levels of soluble protein, but codon harmonization led to proteins with higher thermostability, implying a higher folding quality. Altogether, our study suggests that both codon optimization and codon harmonization are valuable approaches for successful heterologous expression of viral genes in E. coli, but codon harmonization may be preferable in obtaining recombinant viral proteins of higher folding quality.
  •  
7.
  • Bálint, Adám, et al. (författare)
  • Recombination Events Shape the Genomic Evolution of Infectious Bronchitis Virus in Europe
  • 2021
  • Ingår i: Viruses. - : MDPI AG. - 1999-4915. ; 13
  • Tidskriftsartikel (refereegranskat)abstract
    • Infectious bronchitis of chicken is a high morbidity and mortality viral disease affecting the poultry industry worldwide; therefore, a better understanding of this pathogen is of utmost importance. The primary aim of this study was to obtain a deeper insight into the genomic diversity of field infectious bronchitis virus (IBV) strains using phylogenetic and recombination analysis. We sequenced the genome of 20 randomly selected strains from seven European countries. After sequencing, we created a genome sequence data set that contained 36 European origin field isolates and 33 vaccine strains. When analyzing these 69 IBV genome sequences, we identified 215 recombination events highlighting that some strains had multiple recombination breaking points. Recombination hot spots were identified mostly in the regions coding for non-structural proteins, and multiple recombination hot spots were identified in the nsp2, nsp3, nsp8, and nsp12 coding regions. Recombination occurred among different IBV genotypes and involved both field and vaccine IBV strains. Ninety percent of field strains and nearly half of vaccine strains showed evidence of recombination. Despite the low number and the scattered geographical and temporal origin of whole-genome sequence data collected from European Gammacoronaviruses, this study underlines the importance of recombination as a major evolutionary mechanism of IBVs.
  •  
8.
  • Banerjee, Debapriya, et al. (författare)
  • Protein Folding Activity of the Ribosome (PFAR) : A Target for Antiprion Compounds
  • 2014
  • Ingår i: Viruses. - : MDPI AG. - 1999-4915. ; 6:10, s. 3907-3924
  • Forskningsöversikt (refereegranskat)abstract
    • Prion diseases are fatal neurodegenerative diseases affecting mammals. Prions are misfolded amyloid aggregates of the prion protein (PrP), which form when the alpha helical, soluble form of PrP converts to an aggregation-prone, beta sheet form. Thus, prions originate as protein folding problems. The discovery of yeast prion(s) and the development of a red-/white-colony based assay facilitated safe and high-throughput screening of antiprion compounds. With this assay three antiprion compounds; 6-aminophenanthridine (6AP), guanabenz acetate (GA), and imiquimod (IQ) have been identified. Biochemical and genetic studies reveal that these compounds target ribosomal RNA (rRNA) and inhibit specifically the protein folding activity of the ribosome (PFAR). The domain V of the 23S/25S/28S rRNA of the large ribosomal subunit constitutes the active site for PFAR. 6AP and GA inhibit PFAR by competition with the protein substrates for the common binding sites on the domain V rRNA. PFAR inhibition by these antiprion compounds opens up new possibilities for understanding prion formation, propagation and the role of the ribosome therein. In this review, we summarize and analyze the correlation between PFAR and prion processes using the antiprion compounds as tools.
  •  
9.
  • Banse, Pia, et al. (författare)
  • CD81 receptor regions outside the large extracellular loop determine hepatitis C virus entry into hepatoma cells
  • 2018
  • Ingår i: Viruses. - : MDPI AG. - 1999-4915. ; 10:4
  • Tidskriftsartikel (refereegranskat)abstract
    • Hepatitis C virus (HCV) enters human hepatocytes using four essential entry factors, one of which is human CD81 (hCD81). The tetraspanin hCD81 contains a large extracellular loop (LEL), which interacts with the E2 glycoprotein of HCV. The role of the non-LEL regions of hCD81 (intracellular tails, four transmembrane domains, small extracellular loop and intracellular loop) is poorly understood. Here, we studied the contribution of these domains to HCV susceptibility of hepatoma cells by generating chimeras of related tetraspanins with the hCD81 LEL. Our results show that non-LEL regions in addition to the LEL determine susceptibility of cells to HCV. While closely related tetraspanins (X. tropicalis CD81 and D. rerio CD81) functionally complement hCD81 non-LEL regions, distantly related tetraspanins (C. elegans TSP9 amd D. melanogaster TSP96F) do not and tetraspanins with intermediate homology (hCD9) show an intermediate phenotype. Tetraspanin homology and susceptibility to HCV correlate positively. For some chimeras, infectivity correlates with surface expression. In contrast, the hCD9 chimera is fully surface expressed, binds HCV E2 glycoprotein but is impaired in HCV receptor function. We demonstrate that a cholesterol-coordinating glutamate residue in CD81, which hCD9 lacks, promotes HCV infection. This work highlights the hCD81 non-LEL regions as additional HCV susceptibility-determining factors.
  •  
10.
  • Bauer, Wolfgang, et al. (författare)
  • Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection
  • 2021
  • Ingår i: Viruses. - : MDPI. - 1999-4915. ; 13:12
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: We evaluated how plasma proteomic signatures in patients with suspected COVID-19 can unravel the pathophysiology, and determine kinetics and clinical outcome of the infection.Methods: Plasma samples from patients presenting to the emergency department (ED) with symptoms of COVID-19 were stratified into: (1) patients with suspected COVID-19 that was not confirmed (n = 44); (2) non-hospitalized patients with confirmed COVID-19 (n = 44); (3) hospitalized patients with confirmed COVID-19 (n = 53) with variable outcome; and (4) patients presenting to the ED with minor diseases unrelated to SARS-CoV-2 infection (n = 20). Besides standard of care diagnostics, 177 circulating proteins related to inflammation and cardiovascular disease were analyzed using proximity extension assay (PEA, Olink) technology.Results: Comparative proteome analysis revealed 14 distinct proteins as highly associated with SARS-CoV-2 infection and 12 proteins with subsequent hospitalization (p < 0.001). ADM, IL-6, MCP-3, TRAIL-R2, and PD-L1 were each predictive for death (AUROC curve 0.80-0.87). The consistent increase of these markers, from hospital admission to intensive care and fatality, supported the concept that these proteins are of major clinical relevance.Conclusions: We identified distinct plasma proteins linked to the presence and course of COVID-19. These plasma proteomic findings may translate to a protein fingerprint, helping to assist clinical management decisions.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 194
Typ av publikation
tidskriftsartikel (169)
forskningsöversikt (25)
Typ av innehåll
refereegranskat (183)
övrigt vetenskapligt/konstnärligt (11)
Författare/redaktör
Lundkvist, Åke (12)
Belak, Sandor (10)
Dalianis, T (7)
Evander, Magnus (6)
Blomström, Anne-Lie (6)
Hesson, Jenny C., 19 ... (6)
visa fler...
Bergström, Tomas, 19 ... (5)
Mirazimi, A (5)
Lindahl, Johanna (5)
Överby, Anna K. (5)
Bergqvist, Anders (5)
Nordgren, Johan (5)
Arnberg, Niklas, 198 ... (5)
Punga, Tanel, PhD, 1 ... (5)
Rodrigues De Miranda ... (5)
Sonnerborg, A (4)
Naguib, Mahmoud (4)
Nasman, A (4)
Hagag, Naglaa M. (4)
Svensson, Lennart (4)
Frängsmyr, Lars (4)
Ecke, Frauke (4)
Hagbom, Marie (4)
Zupancic, M (4)
Isaguliants, M (3)
Esbjörnsson, Joakim (3)
Trybala, Edward, 195 ... (3)
Liljeqvist, Jan-Åke, ... (3)
Norder, Helene (3)
Hägglund, Sara (3)
Valarcher, Jean-Fran ... (3)
Ling, Jiaxin (3)
Rönnberg, Bengt (3)
Hoffman, Tove (3)
Kolstad, Linda (3)
Melik, Wessam, 1973- (3)
Shahein, Momtaz A. (3)
Upadhyay, S (3)
Ganguly, K (3)
Ianevski, Aleksandr (3)
Zusinaite, Eva (3)
Kainov, Denis E. (3)
Lenman, Annasara, 19 ... (3)
Rahlff, Janina (3)
Bayurova, E (3)
Gordeychuk, I (3)
Holmfeldt, Karin, 19 ... (3)
Vapalahti, Olli (3)
Holzhauser, S (3)
Chandra, Naresh, 198 ... (3)
visa färre...
Lärosäte
Karolinska Institutet (65)
Uppsala universitet (40)
Sveriges Lantbruksuniversitet (36)
Umeå universitet (23)
Göteborgs universitet (17)
Lunds universitet (14)
visa fler...
Linköpings universitet (9)
Linnéuniversitetet (6)
Stockholms universitet (4)
Örebro universitet (4)
Kungliga Tekniska Högskolan (2)
Chalmers tekniska högskola (2)
Högskolan i Halmstad (1)
Sophiahemmet Högskola (1)
visa färre...
Språk
Engelska (194)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (90)
Naturvetenskap (42)
Lantbruksvetenskap (26)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy